Clinical Trial Detail

NCT ID NCT03801915
Title Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

rectum adenocarcinoma

ampulla of Vater adenocarcinoma

colon adenocarcinoma

bile duct adenocarcinoma

pancreatic adenocarcinoma

Therapies

MVT-5873

Age Groups: senior adult

No variant requirements are available.